Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -15.66 Million CAD | -39.22% |
| 2022 | -11.25 Million CAD | -28.06% |
| 2021 | -8.78 Million CAD | 3.44% |
| 2020 | -9.09 Million CAD | -87.2% |
| 2019 | -4.86 Million CAD | -95.26% |
| 2018 | -2.48 Million CAD | 36.81% |
| 2017 | -3.93 Million CAD | 61.19% |
| 2016 | -10.14 Million CAD | -6.56% |
| 2015 | -9.52 Million CAD | -0.34% |
| 2014 | -9.49 Million CAD | 16.05% |
| 2013 | -11.3 Million CAD | -32.35% |
| 2012 | -8.54 Million CAD | -27.26% |
| 2011 | -6.71 Million CAD | -2.22% |
| 2010 | -6.56 Million CAD | -137.59% |
| 2009 | -2.76 Million CAD | -84.02% |
| 2008 | -1.5 Million CAD | 9.84% |
| 2007 | -1.66 Million CAD | -144.66% |
| 2006 | 3.73 Million CAD | 150.69% |
| 2005 | -7.35 Million CAD | -241.28% |
| 2004 | -2.15 Million CAD | 51.36% |
| 2003 | -4.43 Million CAD | 17.43% |
| 2002 | -5.36 Million CAD | -0.02% |
| 2001 | -5.36 Million CAD | 29.37% |
| 2000 | -7.6 Million CAD | 26.21% |
| 1999 | -10.3 Million CAD | 20.16% |
| 1998 | -12.9 Million CAD | 5.15% |
| 1997 | -13.6 Million CAD | 2.86% |
| 1996 | -14 Million CAD | -55.56% |
| 1995 | -9 Million CAD | -164.71% |
| 1994 | -3.4 Million CAD | -6.25% |
| 1993 | -3.2 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -4.16 Million CAD | 36.54% |
| 2024 Q2 | -4.4 Million CAD | -5.82% |
| 2023 Q3 | -3.39 Million CAD | 13.91% |
| 2023 FY | -15.66 Million CAD | -39.22% |
| 2023 Q4 | -6.55 Million CAD | -93.31% |
| 2023 Q1 | -1.77 Million CAD | 28.11% |
| 2023 Q2 | -3.93 Million CAD | -121.67% |
| 2022 Q1 | -2.68 Million CAD | -5.33% |
| 2022 Q2 | -2.95 Million CAD | -9.93% |
| 2022 Q3 | -3.13 Million CAD | -6.09% |
| 2022 FY | -11.25 Million CAD | -28.06% |
| 2022 Q4 | -2.47 Million CAD | 21.15% |
| 2021 Q2 | -2.52 Million CAD | -53.25% |
| 2021 FY | -8.78 Million CAD | 3.44% |
| 2021 Q4 | -2.55 Million CAD | -23.46% |
| 2021 Q3 | -2.06 Million CAD | 18.01% |
| 2021 Q1 | -1.64 Million CAD | 23.38% |
| 2020 Q2 | -1.94 Million CAD | 43.09% |
| 2020 FY | -9.09 Million CAD | -87.2% |
| 2020 Q4 | -2.14 Million CAD | -36.14% |
| 2020 Q1 | -3.42 Million CAD | -142.22% |
| 2020 Q3 | -1.57 Million CAD | 19.09% |
| 2019 Q2 | -1.05 Million CAD | -5.94% |
| 2019 Q1 | -993 Thousand CAD | -323.65% |
| 2019 Q4 | -1.41 Million CAD | -0.93% |
| 2019 FY | -4.86 Million CAD | -95.26% |
| 2019 Q3 | -1.4 Million CAD | -33.17% |
| 2018 Q1 | -714 Thousand CAD | 31.48% |
| 2018 FY | -2.48 Million CAD | 36.81% |
| 2018 Q4 | 444 Thousand CAD | 162.62% |
| 2018 Q3 | -709 Thousand CAD | 53.05% |
| 2018 Q2 | -1.51 Million CAD | -111.48% |
| 2017 Q4 | -1.04 Million CAD | -27.07% |
| 2017 Q1 | -962 Thousand CAD | 6.05% |
| 2017 Q2 | -1.11 Million CAD | -15.9% |
| 2017 Q3 | -820 Thousand CAD | 26.46% |
| 2017 FY | -3.93 Million CAD | 61.19% |
| 2016 Q1 | -2.99 Million CAD | -24.75% |
| 2016 Q2 | -3.49 Million CAD | -16.83% |
| 2016 Q4 | -1.02 Million CAD | 61.11% |
| 2016 Q3 | -2.63 Million CAD | 24.73% |
| 2016 FY | -10.14 Million CAD | -6.56% |
| 2015 Q2 | -2.36 Million CAD | -4.46% |
| 2015 Q1 | -2.26 Million CAD | -22.17% |
| 2015 FY | -9.52 Million CAD | -0.34% |
| 2015 Q4 | -2.4 Million CAD | 3.73% |
| 2015 Q3 | -2.49 Million CAD | -5.37% |
| 2014 Q4 | -1.85 Million CAD | 7.85% |
| 2014 Q1 | -3.17 Million CAD | 13.56% |
| 2014 Q2 | -2.45 Million CAD | 22.8% |
| 2014 Q3 | -2.01 Million CAD | 17.91% |
| 2014 FY | -9.49 Million CAD | 16.05% |
| 2013 Q1 | -2.07 Million CAD | -0.48% |
| 2013 Q4 | -3.67 Million CAD | -45.93% |
| 2013 Q3 | -2.51 Million CAD | 17.2% |
| 2013 Q2 | -3.04 Million CAD | -46.36% |
| 2013 FY | -11.3 Million CAD | -32.35% |
| 2012 Q4 | -2.06 Million CAD | 0.48% |
| 2012 FY | -8.54 Million CAD | -27.26% |
| 2012 Q3 | -2.07 Million CAD | 3.44% |
| 2012 Q2 | -2.15 Million CAD | 4.31% |
| 2012 Q1 | -2.24 Million CAD | -15.88% |
| 2011 Q4 | -1.94 Million CAD | -20.12% |
| 2011 Q2 | -1.7 Million CAD | -16.6% |
| 2011 FY | -6.71 Million CAD | -2.22% |
| 2011 Q1 | -1.45 Million CAD | 29.36% |
| 2011 Q3 | -1.61 Million CAD | 5.0% |
| 2010 Q4 | -2.06 Million CAD | -60.0% |
| 2010 Q2 | -1.27 Million CAD | 34.64% |
| 2010 FY | -6.56 Million CAD | -137.59% |
| 2010 Q1 | -1.94 Million CAD | -57.97% |
| 2010 Q3 | -1.29 Million CAD | -1.57% |
| 2009 Q3 | -429 Thousand CAD | 38.8% |
| 2009 Q1 | -404 Thousand CAD | -33.33% |
| 2009 Q2 | -701 Thousand CAD | -73.51% |
| 2009 FY | -2.76 Million CAD | -84.02% |
| 2009 Q4 | -1.23 Million CAD | -186.71% |
| 2008 Q1 | -448 Thousand CAD | 35.82% |
| 2008 Q4 | -303 Thousand CAD | 8.73% |
| 2008 Q3 | -332 Thousand CAD | 20.76% |
| 2008 Q2 | -419 Thousand CAD | 6.47% |
| 2008 FY | -1.5 Million CAD | 9.84% |
| 2007 FY | -1.66 Million CAD | -144.66% |
| 2007 Q2 | -379 Thousand CAD | -83.09% |
| 2007 Q4 | -698 Thousand CAD | -82.72% |
| 2007 Q3 | -382 Thousand CAD | -0.79% |
| 2007 Q1 | -207 Thousand CAD | 0.0% |
| 2006 FY | 3.73 Million CAD | 150.69% |
| 2006 Q2 | 4.75 Million CAD | 1127.65% |
| 2006 Q1 | 387 Thousand CAD | 121.42% |
| 2006 Q3 | -431 Thousand CAD | -109.07% |
| 2005 Q3 | -1.54 Million CAD | 9.03% |
| 2005 Q4 | -1.8 Million CAD | -17.26% |
| 2005 FY | -7.35 Million CAD | -241.28% |
| 2005 Q1 | -1.96 Million CAD | 6.96% |
| 2005 Q2 | -1.69 Million CAD | 13.79% |
| 2004 Q1 | -1.6 Million CAD | -28.14% |
| 2004 FY | -2.15 Million CAD | 51.36% |
| 2004 Q4 | -2.11 Million CAD | -12.04% |
| 2004 Q3 | -1.88 Million CAD | -34.84% |
| 2004 Q2 | -1.39 Million CAD | 12.79% |
| 2003 FY | -4.43 Million CAD | 17.43% |
| 2003 Q2 | -901 Thousand CAD | 46.72% |
| 2003 Q3 | 2.15 Million CAD | 339.07% |
| 2003 Q4 | -1.25 Million CAD | -158.08% |
| 2003 Q1 | -1.69 Million CAD | -251.56% |
| 2002 FY | -5.36 Million CAD | -0.02% |
| 2002 Q4 | -481 Thousand CAD | 43.01% |
| 2002 Q3 | -844 Thousand CAD | 40.4% |
| 2002 Q2 | -1.41 Million CAD | 57.17% |
| 2002 Q1 | -3.3 Million CAD | -81.45% |
| 2001 FY | -5.36 Million CAD | 29.37% |
| 2001 Q1 | -1.15 Million CAD | -67.29% |
| 2001 Q2 | 1.42 Million CAD | 223.62% |
| 2001 Q3 | -1.67 Million CAD | -216.86% |
| 2001 Q4 | -1.82 Million CAD | -9.1% |
| 2000 FY | -7.6 Million CAD | 26.21% |
| 2000 Q3 | -1.82 Million CAD | -7.47% |
| 2000 Q4 | -691 Thousand CAD | 62.18% |
| 2000 Q1 | -1.1 Million CAD | 26.67% |
| 2000 Q2 | -1.7 Million CAD | -54.55% |
| 1999 Q2 | -2.4 Million CAD | -50.0% |
| 1999 Q4 | -1.5 Million CAD | 42.31% |
| 1999 FY | -10.3 Million CAD | 20.16% |
| 1999 Q1 | -1.6 Million CAD | 42.86% |
| 1999 Q3 | -2.6 Million CAD | -8.33% |
| 1998 Q3 | -3.2 Million CAD | -18.52% |
| 1998 Q4 | -2.8 Million CAD | 12.5% |
| 1998 Q2 | -2.7 Million CAD | 18.18% |
| 1998 Q1 | -3.3 Million CAD | -3.13% |
| 1998 FY | -12.9 Million CAD | 5.15% |
| 1997 FY | -13.6 Million CAD | 2.86% |
| 1997 Q4 | -3.2 Million CAD | 3.03% |
| 1997 Q3 | -3.3 Million CAD | -6.45% |
| 1997 Q1 | -4.9 Million CAD | -58.06% |
| 1997 Q2 | -3.1 Million CAD | 36.73% |
| 1996 Q1 | -3 Million CAD | 16.67% |
| 1996 Q4 | -3.1 Million CAD | -10.71% |
| 1996 FY | -14 Million CAD | -55.56% |
| 1996 Q3 | -2.8 Million CAD | 0.0% |
| 1996 Q2 | -2.8 Million CAD | 6.67% |
| 1995 FY | -9 Million CAD | -164.71% |
| 1995 Q4 | -3.6 Million CAD | 12.2% |
| 1995 Q1 | -3 Million CAD | -57.89% |
| 1995 Q3 | -4.1 Million CAD | -24.24% |
| 1995 Q2 | -3.3 Million CAD | -10.0% |
| 1994 Q1 | -600 Thousand CAD | 50.0% |
| 1994 Q3 | -2.5 Million CAD | -56.25% |
| 1994 Q4 | -1.9 Million CAD | 24.0% |
| 1994 FY | -3.4 Million CAD | -6.25% |
| 1994 Q2 | -1.6 Million CAD | -166.67% |
| 1993 Q4 | -1.2 Million CAD | -9.09% |
| 1993 FY | -3.2 Million CAD | 0.0% |
| 1993 Q1 | -518.13 Thousand CAD | -35.24% |
| 1993 Q3 | -1.1 Million CAD | -120.0% |
| 1993 Q2 | -500 Thousand CAD | 3.5% |
| 1992 Q3 | -2.12 Million CAD | -254.68% |
| 1992 Q2 | -598.08 Thousand CAD | 0.0% |
| 1992 Q4 | -383.12 Thousand CAD | 81.94% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -1010.78% |
| Arrayit Corporation | -3.31 Million USD | -372.374% |
| Atlantic International Corp. | -5.62 Million USD | -178.307% |
| Biocept, Inc. | -32.08 Million USD | 51.189% |
| Bioqual, Inc. | 483.48 Thousand USD | 3339.424% |
| CardioGenics Holdings Inc | -1.91 Million USD | -717.294% |
| DermTech, Inc. | -100.88 Million USD | 84.476% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.773% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 27.472% |
| iMD Companies, Inc. | -200.63 Thousand USD | -7706.176% |
| IDenta Corp. | 14.64 Thousand USD | 107051.653% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 2052.868% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 40581.791% |
| InVitro International | 1553.00 USD | 1008599.678% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -82.286% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -26851.404% |
| Medical Imaging Corp. | -3.02 Million USD | -418.09% |
| NovelStem International Corp. | -4.18 Million USD | -274.036% |
| Optigenex Inc. | -2.89 Million USD | -440.486% |
| PharmChem, Inc. | 845.1 Thousand USD | 1953.267% |
| Proteome Sciences plc | -2.44 Million USD | -541.097% |
| Response Genetics, Inc | -20.18 Million USD | 22.404% |
| Rennova Health, Inc. | -3.29 Million USD | -375.607% |
| RushNet, Inc. | -607.02 Thousand USD | -2480.112% |
| ScreenPro Security Inc. | -2.24 Million USD | -596.471% |
| Stella Diagnostics Inc. | -5.7 Million USD | -174.414% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -37.201% |
| Todos Medical Ltd. | -24.99 Million USD | 37.337% |